{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:40:00Z","timestamp":1773286800343,"version":"3.50.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T00:00:00Z","timestamp":1247097600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s00345-009-0446-5","type":"journal-article","created":{"date-parts":[[2009,7,8]],"date-time":"2009-07-08T06:52:52Z","timestamp":1247035972000},"source":"Crossref","is-referenced-by-count":29,"title":["Basic mechanisms of urgency: roles and benefits of pharmacotherapy"],"prefix":"10.1007","volume":"27","author":[{"given":"Martin Christian","family":"Michel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher R.","family":"Chapple","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,9]]},"reference":[{"key":"446_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/nau.10052","volume":"21","author":"P Abrams","year":"2002","unstructured":"Abrams P, Cardozo L, Fall M et al (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21:167\u2013178","journal-title":"Neurourol Urodyn"},{"key":"446_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2009.05.028","author":"MC Michel","year":"2009","unstructured":"Michel MC, Chapple CR (2009) Basic mechanisms of urgency: basic and clinical evidence. Eur Urol. doi:\n                    10.1016\/j.eururo.2009.05.028","journal-title":"Eur Urol"},{"key":"446_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/nau.10082","volume":"22","author":"S Oliver","year":"2003","unstructured":"Oliver S, Fowler C, Mundy A et al (2003) Measuring the sensation of urge and bladder filling during cystometry in urge incontinence and the effect of neuromodulation. Neurourol Urodyn 22:7\u201316","journal-title":"Neurourol Urodyn"},{"key":"446_CR4","doi-asserted-by":"publisher","first-page":"661.e1","DOI":"10.1016\/j.ajog.2008.02.023","volume":"198","author":"L Lowenstein","year":"2008","unstructured":"Lowenstein L, Fitzgerald MP, Kenton K et al (2008) Validation of a real-time urodynamic measure of urinary sensation. Am J Obstet Gynecol 198:661.e1\u2013661.e5","journal-title":"Am J Obstet Gynecol"},{"key":"446_CR5","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1097\/01.ju.0000142429.59753.5c","volume":"172","author":"J-J Wyndaele","year":"2004","unstructured":"Wyndaele J-J, van Meel TD, de Wachter S (2004) Detrusor overactivity. Does it represent a difference if patients feel the involuntary contractions? J Urol 172:1915\u20131918","journal-title":"J Urol"},{"key":"446_CR6","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1046\/j.1464-410X.2003.04351.x","volume":"92","author":"J Malone-Lee","year":"2003","unstructured":"Malone-Lee J, Henshaw DJE, Cummings K (2003) Urodynamic verification of an overactive bladder is not a prerequisite for antimuscarinic treatment response. BJU Int 92:415\u2013417","journal-title":"BJU Int"},{"key":"446_CR7","unstructured":"Rovner E, Payne C, Yalla S et al (2005) Response to fesoterodine in overactive bladder (OAB) patients is independent of the uryodynamic finding of detrusor overactivity. \n                    https:\/\/www.icsoffice.org\/publications\/2005\/PDF\/0147.PDF"},{"key":"446_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/nau.20093","volume":"24","author":"G Matharu","year":"2005","unstructured":"Matharu G, Donaldson MMK, McGrother CW et al (2005) Relationship between urinary symptoms reported in a postal questionnaire and urodynamic diagnosis. Neurourol Urodyn 24:100\u2013105","journal-title":"Neurourol Urodyn"},{"key":"446_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0022-5347(05)00067-4","volume":"175","author":"H Hashim","year":"2006","unstructured":"Hashim H, Abrams P (2006) Is the bladder a reliable witness for predicting detrusor overactivity? J Urol 175:191\u2013195","journal-title":"J Urol"},{"key":"446_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00192-006-0165-z","volume":"18","author":"BT Haylen","year":"2007","unstructured":"Haylen BT, Chetty N, Logan V et al (2007) Is sensory urgency part of the same spectrum of bladder dysfunction as detrusor overactivity? Int Urogynecol J 18:123\u2013128","journal-title":"Int Urogynecol J"},{"key":"446_CR11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/nau.20523","volume":"27","author":"S Wachter de","year":"2008","unstructured":"de Wachter S, van Meel TD, Wyndaele J-J (2008) Can a faked cystometry deceive patients in their perception of filling sensations? A study on the reliability of spontaneous reported cystometric filling sensations in patients with non-neurogenic lower urinary tract dysfunction. Neurourol Urodyn 27:395\u2013398","journal-title":"Neurourol Urodyn"},{"key":"446_CR12","first-page":"363","volume-title":"Neural control","author":"J Morrison","year":"2006","unstructured":"Morrison J, Birder LA, Craggs M et al (2006) Neural control. Plymbridge Distributors Ltd, Plymouth, pp 363\u2013422"},{"key":"446_CR13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1469-445X.1999.tb00078.x","volume":"84","author":"J Morrison","year":"1999","unstructured":"Morrison J (1999) The activation of bladder wall afferent nerves. Exp Physiol 84:131\u2013136","journal-title":"Exp Physiol"},{"key":"446_CR14","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.eururo.2006.10.028","volume":"51","author":"KS Lips","year":"2007","unstructured":"Lips KS, Wunsch J, Sarghooni S et al (2007) Acetylcholine and molecular components of its synthesis and release machinery in the urothelium. Eur Urol 51:1042\u20131053","journal-title":"Eur Urol"},{"key":"446_CR15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1254\/jphs.FM0070115","volume":"106","author":"M Yoshida","year":"2008","unstructured":"Yoshida M, Masunaga K, Satoji Y et al (2008) Basic and clinical aspects of non-neuronal acetylcholine: expression of non-neuronal acetylcholine in urothelium and its clinical significance. J Pharmacol Sci 106:193\u2013198","journal-title":"J Pharmacol Sci"},{"key":"446_CR16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00210-007-0209-z","volume":"377","author":"N Yoshimura","year":"2008","unstructured":"Yoshimura N, Kaiho Y, Miyazato M et al (2008) Therapeutic targets for lower urinary tract dysfunction. Naunyn Schmiedebergs Arch Pharmacol 377:437\u2013448","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"446_CR17","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/nau.20177","volume":"24","author":"MP Fitzgerald","year":"2005","unstructured":"Fitzgerald MP, Kenton KS, Brubaker L (2005) Localization of the urge to void in patients with painful bladder syndrome. Neurourol Urodyn 24:633\u2013637","journal-title":"Neurourol Urodyn"},{"key":"446_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000075265","volume":"72","author":"P Bulmer","year":"2004","unstructured":"Bulmer P, Abrams P (2004) The unstable detrusor. Urol Int 72:1\u201312","journal-title":"Urol Int"},{"key":"446_CR19","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/brain\/124.2.369","volume":"124","author":"BS Athwal","year":"2001","unstructured":"Athwal BS, Berkley KJ, Hussain I et al (2001) Brain responses to changes in bladder volume and urge to void in healthy men. Brain 124:369\u2013377","journal-title":"Brain"},{"key":"446_CR20","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/nau.20549","volume":"27","author":"D Griffiths","year":"2008","unstructured":"Griffiths D, Tadic SD (2008) Bladder control, urgency, and urge incontinence: evidence from functional brain imaging. Neurourol Urodyn 27:466\u2013474","journal-title":"Neurourol Urodyn"},{"issue":"Suppl 3A","key":"446_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.urology.2003.10.005","volume":"63","author":"K-E Andersson","year":"2004","unstructured":"Andersson K-E (2004) New pharmacological targets for the treatment of the overactive bladder: an update. Urology 63(Suppl 3A):32\u201341","journal-title":"Urology"},{"key":"446_CR22","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0022-5347(05)00004-2","volume":"175","author":"M Kono","year":"2006","unstructured":"Kono M, Nakamura Y, Ishiura Y et al (2006) Central muscarinic receptor subtypes regulating voiding in rats. J Urol 175:353\u2013357","journal-title":"J Urol"},{"key":"446_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/nau.20217","volume":"25","author":"A Cucchi","year":"2006","unstructured":"Cucchi A, Quaglini S, Siracusano S et al (2006) Urgency degree and bladder contraction velocity: sequential changes in women with idiopathic detrusor overactivity. Neurourol Urodyn 25:123\u2013127","journal-title":"Neurourol Urodyn"},{"key":"446_CR24","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.juro.2007.03.122","volume":"178","author":"A Cucchi","year":"2007","unstructured":"Cucchi A, Quaglini S, Rovereto B (2007) Relationships between micturition urgency and involuntary voiding dynamics in men with urinary incontinence from idiopathic detrusor overactivity. J Urol 178:563\u2013567","journal-title":"J Urol"},{"key":"446_CR25","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1124\/jpet.103.063735","volume":"309","author":"T Schneider","year":"2004","unstructured":"Schneider T, Fetscher C, Krege S et al (2004) Signal transduction underlying carbachol-induced contraction of human urinary bladder. J Pharmacol Exp Ther 309:1148\u20131153","journal-title":"J Pharmacol Exp Ther"},{"key":"446_CR26","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00210-007-0208-0","volume":"377","author":"EP Frazier","year":"2008","unstructured":"Frazier EP, Peters SLM, Braverman AS et al (2008) Signal transduction underlying control of urinary bladder smooth muscle tone by muscarinic receptors and \u03b2-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 377:449\u2013462","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"446_CR27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.eururo.2005.04.019","volume":"48","author":"DE Rapp","year":"2005","unstructured":"Rapp DE, Lyon MB, Bales GT et al (2005) A role for the P2X receptor in urinary tract physiology and in the pathophysiology of urinary dysfunction. Eur Urol 48:303\u2013308","journal-title":"Eur Urol"},{"key":"446_CR28","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1113\/jphysiol.1984.sp015386","volume":"354","author":"GN Sibley","year":"1984","unstructured":"Sibley GN (1984) A comparison of spontaneous and nerve-mediated activity in bladder muscle from man, pig and rabbit. J Physiol (Lond) 354:431\u2013443","journal-title":"J Physiol (Lond)"},{"key":"446_CR29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1469-445X.1999.tb00081.x","volume":"84","author":"CH Fry","year":"1999","unstructured":"Fry CH, Wu C, Mundy AR (1999) Bladder instability and detrusor smooth muscle function. Exp Physiol 84:161\u2013169","journal-title":"Exp Physiol"},{"issue":"Suppl 5A","key":"446_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0090-4295(01)01632-6","volume":"59","author":"CH Fry","year":"2002","unstructured":"Fry CH, Skennerton D, Wood D et al (2002) The cellular basis of contraction in human detrusor smooth muscle from patients with stable and unstable bladders. Urology 59(Suppl 5A):3\u201312","journal-title":"Urology"},{"key":"446_CR31","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.tips.2006.07.002","volume":"27","author":"SLM Peters","year":"2006","unstructured":"Peters SLM, Schmidt M, Michel MC (2006) Rho kinase: a target for treating urinary bladder dysfunction? Trends Pharmacol Sci 27:492\u2013497","journal-title":"Trends Pharmacol Sci"},{"key":"446_CR32","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.vascn.2004.03.002","volume":"49","author":"CH Fry","year":"2004","unstructured":"Fry CH (2004) Experimental models to study the physiology, pathophysiology and pharmacology of the lower urinary tract. J Pharmacol Toxicol Methods 49:201\u2013210","journal-title":"J Pharmacol Toxicol Methods"},{"key":"446_CR33","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/nau.1930120504","volume":"12","author":"BL Coolsaet","year":"1993","unstructured":"Coolsaet BL, van Duyl WA, van Os-Bossagh P et al (1993) New concepts in relation to urge and detrusor overactivity. Neurourol Urodyn 12:463\u2013471","journal-title":"Neurourol Urodyn"},{"key":"446_CR34","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1111\/j.1464-410X.2005.05455.x","volume":"95","author":"MJ Drake","year":"2005","unstructured":"Drake MJ, Harvey IJ, Gillespie JI et al (2005) Localized contractions in the normal human bladder and in urinary urgency. BJU Int 95:1002\u20131005","journal-title":"BJU Int"},{"key":"446_CR35","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/nau.1930080209","volume":"8","author":"A Elbadawi","year":"1989","unstructured":"Elbadawi A, Meyer S (1989) Morphometry of the obstructed detrusor. I. Review of the issues. Neurourol Urodyn 8:163\u2013171","journal-title":"Neurourol Urodyn"},{"key":"446_CR36","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/00005392-200101000-00072","volume":"165","author":"JE Greenland","year":"2001","unstructured":"Greenland JE, Brading AF (2001) The effect of bladder outflow obstruction on detrusor blood flow changes during the voiding cycle in conscious pigs. J Urol 165:245\u2013248","journal-title":"J Urol"},{"key":"446_CR37","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.pharmthera.2007.12.001","volume":"117","author":"MC Michel","year":"2008","unstructured":"Michel MC, Barendrecht MM (2008) Physiological and pathological regulation of the autonomic control of urinary bladder contractility. Pharmacol Ther 117:297\u2013312","journal-title":"Pharmacol Ther"},{"key":"446_CR38","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0022-5347(17)56918-9","volume":"121","author":"PH Abrams","year":"1979","unstructured":"Abrams PH, Farrar DJ, Turner-Warwick RT et al (1979) The results of prostatectomy: a symptomatic and urodynamic analysis in 152 patients. J Urol 121:640\u2013642","journal-title":"J Urol"},{"key":"446_CR39","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.eururo.2008.06.047","volume":"54","author":"CR Chapple","year":"2008","unstructured":"Chapple CR, Khullar V, Gabriel Z et al (2008) The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur Urol 54:543\u2013562","journal-title":"Eur Urol"},{"key":"446_CR40","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.eururo.2008.06.080","volume":"54","author":"G Novara","year":"2008","unstructured":"Novara G, Galfano A, Secco S et al (2008) A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder. Eur Urol 54:740\u2013764","journal-title":"Eur Urol"},{"key":"446_CR41","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/nau.20367","volume":"26","author":"MC Michel","year":"2007","unstructured":"Michel MC, Oelke M, Goepel M et al (2007) Relationships among symptoms, bother, and treatment satisfaction in overactive bladder patients. Neurourol Urodyn 26:190\u2013195","journal-title":"Neurourol Urodyn"},{"key":"446_CR42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/nau.20472","volume":"27","author":"JS Starkman","year":"2008","unstructured":"Starkman JS, Dmochowski RR (2008) Urgency assessment in the evaluation of overactive bladder (OAB). Neurourol Urodyn 27:13\u201321","journal-title":"Neurourol Urodyn"},{"key":"446_CR43","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.eururo.2004.01.008","volume":"45","author":"F Haab","year":"2004","unstructured":"Haab F, Stewart L, Dwyer P (2004) Darifenacin, an M3 selective receptor antagonist, is an effective and well-tolerated once-daily treatment for overactive bladder. Eur Urol 45:420\u2013429","journal-title":"Eur Urol"},{"key":"446_CR44","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/j.1464-410X.2005.05343.x","volume":"95","author":"WD Steers","year":"2005","unstructured":"Steers WD, Corcos J, Foote J et al (2005) An investigation of dose titration with darifenacin, an M3-selective receptor antagonist. BJU Int 95:580\u2013586","journal-title":"BJU Int"},{"key":"446_CR45","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.urology.2007.12.017","volume":"71","author":"V Khullar","year":"2008","unstructured":"Khullar V, Rovner ES, Dmochowski R et al (2008) Fesoterodine dose response in subjects with overactive bladder syndrome. Urology 71:839\u2013843","journal-title":"Urology"},{"key":"446_CR46","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.eururo.2007.07.009","volume":"52","author":"C Chapple","year":"2007","unstructured":"Chapple C, van Kerrebroeck P, Tubaro A et al (2007) Clinical efficacy, safety and tolerability of once-daily fesoterodine in subjects with overactive bladder. Eur Urol 52:1204\u20131212","journal-title":"Eur Urol"},{"key":"446_CR47","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1016\/j.juro.2007.08.033","volume":"178","author":"VW Nitti","year":"2007","unstructured":"Nitti VW, Dmochowski R, Sand PK et al (2007) Efficacy, safety and tolerability of fesoterodine for overactive bladder syndrome. J Urol 178:2488\u20132494","journal-title":"J Urol"},{"key":"446_CR48","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1464-410X.2007.07031.x","volume":"100","author":"O Yamaguchi","year":"2007","unstructured":"Yamaguchi O, Marui E, Kakizaki H et al (2007) Randomized, double-blind, placebo- and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder. BJU Int 100:579\u2013587","journal-title":"BJU Int"},{"key":"446_CR49","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1464-410X.2004.04561.x","volume":"93","author":"CR Chapple","year":"2004","unstructured":"Chapple CR, Arano P, Bosch JLHR et al (2004) Solifenacin appears effective and well tolerated in patients with symptomatic idiopathic detrusor overactivity in a placebo- and tolterodine-controlled phase 2 dose-finding study. BJU Int 93:71\u201377","journal-title":"BJU Int"},{"key":"446_CR50","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1464-410X.2004.04606.x","volume":"93","author":"CR Chapple","year":"2004","unstructured":"Chapple CR, Rechberger T, Al-Shukri S et al (2004) Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder. BJU Int 93:303\u2013310","journal-title":"BJU Int"},{"key":"446_CR51","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1097\/01.ju.0000140729.07840.16","volume":"172","author":"L Cardozo","year":"2004","unstructured":"Cardozo L, Lisec M, Millard R et al (2004) Randomized, double-blind placebo-controlled trial of the once-daily antimuscarinic agent solifenacin succinate in patients with overactive bladder. J Urol 172:1919\u20131924","journal-title":"J Urol"},{"issue":"Suppl 3","key":"446_CR52","first-page":"94","volume":"83","author":"MC Gittelman","year":"2003","unstructured":"Gittelman MC (2003) The efficacy and safety of solifenacin in adults with overactive bladder: a multicenter, placebo-controlled study. Int J Gynaecol Obstet 83(Suppl 3):94","journal-title":"Int J Gynaecol Obstet"},{"key":"446_CR53","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.urology.2006.03.006","volume":"68","author":"SA Kaplan","year":"2006","unstructured":"Kaplan SA, Roehrborn CG, Dmochowski R et al (2006) Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia. Urology 68:328\u2013332","journal-title":"Urology"},{"key":"446_CR54","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.urology.2004.02.029","volume":"64","author":"V Khullar","year":"2004","unstructured":"Khullar V, Hill S, Laval K-U et al (2004) Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial. Urology 64:269\u2013275","journal-title":"Urology"},{"key":"446_CR55","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1097\/01.ju.0000127742.73136.0c","volume":"171","author":"N Zinner","year":"2004","unstructured":"Zinner N, Gittelman M, Harris R et al (2004) Trospium chloride improves overactive bladder symptoms: a multicenter phase III trial. J Urol 171:2311\u20132315","journal-title":"J Urol"},{"key":"446_CR56","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0029-7844(03)00623-9","volume":"102","author":"R Freeman","year":"2003","unstructured":"Freeman R, Hill S, Millard R et al (2003) Reduced perception of urgency in treatment of overactive bladder with extended-release tolterodine. Obstet Gynecol 102:605\u2013611","journal-title":"Obstet Gynecol"},{"key":"446_CR57","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1097\/01.ju.0000155798.78911.57","volume":"173","author":"L Cardozo","year":"2005","unstructured":"Cardozo L, Dixon A (2005) Increased warning time with darifenacin: a new concept in the management of urinary urgency. J Urol 173:1214\u20131218","journal-title":"J Urol"},{"key":"446_CR58","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1464-410X.2005.05345.x","volume":"95","author":"L Cardozo","year":"2005","unstructured":"Cardozo L, Coyne KS, Versi E (2005) Validation of the urgency perception scale. BJU Int 95:591\u2013596","journal-title":"BJU Int"},{"key":"446_CR59","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1097\/01.ju.0000154692.73129.d8","volume":"173","author":"N Zinner","year":"2005","unstructured":"Zinner N, Harnett M, Sabounjian L et al (2005) The overactive bladder-symptom composite score: a composite symptom score of toilet voids, urgency severity and urge urinary incontinence in patients with overactive bladder. J Urol 173:1639\u20131643","journal-title":"J Urol"},{"key":"446_CR60","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.eururo.2006.10.005","volume":"51","author":"R Dmochowski","year":"2007","unstructured":"Dmochowski R, Abrams P, Marschall-Kehrel D et al (2007) Efficacy and tolerability of tolterodine extended release in male and female patients with overactive bladder. Eur Urol 51:1054\u20131064","journal-title":"Eur Urol"},{"key":"446_CR61","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1111\/j.1464-410X.2006.06146.x","volume":"97","author":"VW Nitti","year":"2006","unstructured":"Nitti VW, Dmochowski R, Appell RA et al (2006) Efficacy and tolerability of tolterodine extended-release in continent patients with overactive bladder and nocturia. BJU Int 97:1262\u20131266","journal-title":"BJU Int"},{"key":"446_CR62","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.eururo.2004.11.012","volume":"48","author":"MC Michel","year":"2005","unstructured":"Michel MC, de la Rosette JJMCH, Piro M et al (2005) Comparison of symptom severity and treatment response in patients with incontinent and continent overactive bladder. Eur Urol 48:110\u2013115","journal-title":"Eur Urol"},{"key":"446_CR63","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1046\/j.1464-410x.1999.00251.x","volume":"84","author":"H Madersbacher","year":"1999","unstructured":"Madersbacher H, Halaska M, Voigt R et al (1999) A placebo-controlled, multicentre study comparing the tolerability and efficacy of propiverine and oxybutynin in patients with urgency and urge incontinence. BJU Int 84:646\u2013651","journal-title":"BJU Int"},{"key":"446_CR64","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/j.1464-410X.2007.07162.x","volume":"100","author":"D Robinson","year":"2007","unstructured":"Robinson D, Cardozo L, Terpstra G et al (2007) A randomized double-blind placebo-controlled multicentre study to explore the efficacy and safety of tamsulosin and tolterodine in women with overactive bladder syndrome. BJU Int 100:840\u2013845","journal-title":"BJU Int"},{"key":"446_CR65","first-page":"239","volume":"7","author":"CR Chapple","year":"2008","unstructured":"Chapple CR, Yamaguchi O, Ridder A et al (2008) Clinical proof of concept study (Blossom) shows novel \u03b23 adrenoceptor agonist YM178 is effective and well tolerated in the treatment of symptoms of overactive bladder. Eur Urol (Suppl 7):239","journal-title":"Eur Urol Suppl"},{"key":"446_CR66","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00210-006-0073-2","volume":"373","author":"A Avelino","year":"2006","unstructured":"Avelino A, Cruz F (2006) TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications. Naunyn Schmiedebergs Arch Pharmacol 373:287\u2013299","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"446_CR67","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.eururo.2007.10.013","volume":"53","author":"G Karsenty","year":"2008","unstructured":"Karsenty G, Denys P, Amarenco G et al (2008) Botulinum toxin A (Botox\u00ae) intradetrusor injections in adults with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic literature review. Eur Urol 53:275\u2013287","journal-title":"Eur Urol"},{"key":"446_CR68","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/nau.20500","volume":"26","author":"K-E Andersson","year":"2007","unstructured":"Andersson K-E (2007) LUTS treatment: future treatment options. Neurourol Urodyn 26:934\u2013947","journal-title":"Neurourol Urodyn"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-009-0446-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-009-0446-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-009-0446-5.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-009-0446-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,7]],"date-time":"2019-04-07T08:18:22Z","timestamp":1554625102000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-009-0446-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,9]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["446"],"URL":"https:\/\/doi.org\/10.1007\/s00345-009-0446-5","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,9]]},"article-number":"705"}}